{"entity":{"type":"insider","cik":"0001806384","url":"/insider/0001806384","json_url":"/insider/0001806384.json","name":"Mosseri Marlio Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":46,"n_filings":27,"first":"2023-06-16","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Mosseri Marlio Charles","source":"filing","n_filings":27,"first_seen":"2023-06-16","last_seen":"2026-07-01"}],"transactions":[{"id":5761784,"accession":"0001104659-26-079793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-079793","line_url":"/filing/0001104659-26-079793#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":18.32,"price_display":"18.32","price_state":"stated","total_value":916000.0,"total_display":"916,000.00","total_whole":"916,000","shares_owned_after":3186576.0,"shares_owned_after_display":"3,186,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":4875820,"accession":"0001104659-25-103522","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-103522","line_url":"/filing/0001104659-25-103522#line-3","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72836.0,"shares_display":"72,836","price_per_share":6.28,"price_display":"6.28","price_state":"stated","total_value":457410.08,"total_display":"457,410.08","total_whole":"457,410","shares_owned_after":3136576.0,"shares_owned_after_display":"3,136,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-29","scope":"insider"},{"id":4875817,"accession":"0001104659-25-103522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-103522","line_url":"/filing/0001104659-25-103522#line-2","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35034.0,"shares_display":"35,034","price_per_share":6.15,"price_display":"6.15","price_state":"stated","total_value":215459.1,"total_display":"215,459.10","total_whole":"215,459","shares_owned_after":3063740.0,"shares_owned_after_display":"3,063,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-24","filed_date":"2025-10-29","scope":"insider"},{"id":4875812,"accession":"0001104659-25-103522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-103522","line_url":"/filing/0001104659-25-103522#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46900.0,"shares_display":"46,900","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":284214.0,"total_display":"284,214.00","total_whole":"284,214","shares_owned_after":3028706.0,"shares_owned_after_display":"3,028,706","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-23","filed_date":"2025-10-29","scope":"insider"},{"id":4666605,"accession":"0001104659-25-062168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-062168","line_url":"/filing/0001104659-25-062168#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5603.0,"shares_display":"5,603","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":44767.97,"total_display":"44,767.97","total_whole":"44,768","shares_owned_after":2981806.0,"shares_owned_after_display":"2,981,806","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-24","scope":"insider"},{"id":4392156,"accession":"0001104659-25-060965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-060965","line_url":"/filing/0001104659-25-060965#line-2","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28043.0,"shares_display":"28,043","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":225746.15,"total_display":"225,746.15","total_whole":"225,746","shares_owned_after":2976203.0,"shares_owned_after_display":"2,976,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":4392151,"accession":"0001104659-25-060965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-060965","line_url":"/filing/0001104659-25-060965#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5399.0,"shares_display":"5,399","price_per_share":8.11,"price_display":"8.11","price_state":"stated","total_value":43785.89,"total_display":"43,785.89","total_whole":"43,786","shares_owned_after":2948160.0,"shares_owned_after_display":"2,948,160","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-20","scope":"insider"},{"id":5128705,"accession":"0001104659-25-047938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-047938","line_url":"/filing/0001104659-25-047938#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21167.0,"shares_display":"21,167","price_per_share":8.11,"price_display":"8.11","price_state":"stated","total_value":171664.37,"total_display":"171,664.37","total_whole":"171,664","shares_owned_after":2942761.0,"shares_owned_after_display":"2,942,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-13","scope":"insider"},{"id":9223951,"accession":"0001104659-25-047089","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-25-047089","line_url":"/filing/0001104659-25-047089","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25062.0,"shares_display":"25,062","price_per_share":8.936438420716623,"price_display":"8.94","price_state":"stated","total_value":223965.0197,"total_display":"223,965.02","total_whole":"223,965","shares_owned_after":2936594.0,"shares_owned_after_display":"2,936,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-12","scope":"insider","n_lines":3},{"id":9223949,"accession":"0001104659-25-047089","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-047089","line_url":"/filing/0001104659-25-047089","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2600.0,"shares_display":"2,600","price_per_share":8.96076923076923,"price_display":"8.96","price_state":"stated","total_value":23298.0,"total_display":"23,298.00","total_whole":"23,298","shares_owned_after":2911532.0,"shares_owned_after_display":"2,911,532","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-08","filed_date":"2025-05-12","scope":"insider","n_lines":3},{"id":4198974,"accession":"0001104659-25-046882","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-25-046882","line_url":"/filing/0001104659-25-046882","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2650.0,"shares_display":"2,650","price_per_share":8.65,"price_display":"8.65","price_state":"stated","total_value":22922.5,"total_display":"22,922.50","total_whole":"22,923","shares_owned_after":2911532.0,"shares_owned_after_display":"2,911,532","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-08","filed_date":"2025-05-09","scope":"insider","n_lines":4},{"id":4198961,"accession":"0001104659-25-046882","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-046882","line_url":"/filing/0001104659-25-046882","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12317.0,"shares_display":"12,317","price_per_share":8.587331330681172,"price_display":"8.59","price_state":"stated","total_value":105770.16,"total_display":"105,770.16","total_whole":"105,770","shares_owned_after":2908882.0,"shares_owned_after_display":"2,908,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-07","filed_date":"2025-05-09","scope":"insider","n_lines":2},{"id":4198956,"accession":"0001104659-25-046882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-046882","line_url":"/filing/0001104659-25-046882","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12444.0,"shares_display":"12,444","price_per_share":8.594869816779172,"price_display":"8.59","price_state":"stated","total_value":106954.56,"total_display":"106,954.56","total_whole":"106,955","shares_owned_after":2896565.0,"shares_owned_after_display":"2,896,565","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-06","filed_date":"2025-05-09","scope":"insider","n_lines":2},{"id":4051991,"accession":"0001104659-25-011588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-011588","line_url":"/filing/0001104659-25-011588#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":240000.0,"shares_display":"240,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1200000.0,"total_display":"1,200,000.00","total_whole":"1,200,000","shares_owned_after":2884121.0,"shares_owned_after_display":"2,884,121","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-07","filed_date":"2025-02-11","scope":"insider"},{"id":9223927,"accession":"0001104659-24-129009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-129009","line_url":"/filing/0001104659-24-129009#line-2","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":79900.0,"total_display":"79,900.00","total_whole":"79,900","shares_owned_after":2644121.0,"shares_owned_after_display":"2,644,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-16","scope":"insider"},{"id":2108299,"accession":"0001104659-24-128688","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-128688","line_url":"/filing/0001104659-24-128688#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":79900.0,"total_display":"79,900.00","total_whole":"79,900","shares_owned_after":2612000.0,"shares_owned_after_display":"2,612,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-16","scope":"insider"},{"id":9223928,"accession":"0001104659-24-129009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-129009","line_url":"/filing/0001104659-24-129009#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32121.0,"shares_display":"32,121","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":149041.44,"total_display":"149,041.44","total_whole":"149,041","shares_owned_after":2627121.0,"shares_owned_after_display":"2,627,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-12","filed_date":"2024-12-16","scope":"insider"},{"id":8522083,"accession":"0001104659-23-086060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-086060","line_url":"/filing/0001104659-23-086060#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":860.0,"shares_display":"860","price_per_share":13.88,"price_display":"13.88","price_state":"stated","total_value":11936.8,"total_display":"11,936.80","total_whole":"11,937","shares_owned_after":2595000.0,"shares_owned_after_display":"2,595,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-01","scope":"insider"},{"id":8586388,"accession":"0001104659-23-085603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-085603","line_url":"/filing/0001104659-23-085603#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2584.0,"shares_display":"2,584","price_per_share":13.91,"price_display":"13.91","price_state":"stated","total_value":35943.44,"total_display":"35,943.44","total_whole":"35,943","shares_owned_after":2594140.0,"shares_owned_after_display":"2,594,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-31","scope":"insider"},{"id":8586384,"accession":"0001104659-23-085087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-085087","line_url":"/filing/0001104659-23-085087#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1556.0,"shares_display":"1,556","price_per_share":13.98,"price_display":"13.98","price_state":"stated","total_value":21752.88,"total_display":"21,752.88","total_whole":"21,753","shares_owned_after":2591556.0,"shares_owned_after_display":"2,591,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-27","filed_date":"2023-07-28","scope":"insider"},{"id":8729042,"accession":"0001104659-23-084523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-084523","line_url":"/filing/0001104659-23-084523#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":13.97,"price_display":"13.97","price_state":"stated","total_value":139700.0,"total_display":"139,700.00","total_whole":"139,700","shares_owned_after":2590000.0,"shares_owned_after_display":"2,590,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-26","filed_date":"2023-07-27","scope":"insider"},{"id":8001209,"accession":"0001104659-23-083470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-083470","line_url":"/filing/0001104659-23-083470#line-2","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2844.0,"shares_display":"2,844","price_per_share":14.61,"price_display":"14.61","price_state":"stated","total_value":41550.84,"total_display":"41,550.84","total_whole":"41,551","shares_owned_after":2580000.0,"shares_owned_after_display":"2,580,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-21","filed_date":"2023-07-24","scope":"insider"},{"id":8001205,"accession":"0001104659-23-083470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-083470","line_url":"/filing/0001104659-23-083470#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5394.0,"shares_display":"5,394","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":77673.6,"total_display":"77,673.60","total_whole":"77,674","shares_owned_after":2577156.0,"shares_owned_after_display":"2,577,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-24","scope":"insider"},{"id":7804025,"accession":"0001104659-23-082536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-082536","line_url":"/filing/0001104659-23-082536#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":14.84,"price_display":"14.84","price_state":"stated","total_value":118720.0,"total_display":"118,720.00","total_whole":"118,720","shares_owned_after":2571762.0,"shares_owned_after_display":"2,571,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-20","scope":"insider"},{"id":7925107,"accession":"0001104659-23-082196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-082196","line_url":"/filing/0001104659-23-082196#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9149.0,"shares_display":"9,149","price_per_share":14.84,"price_display":"14.84","price_state":"stated","total_value":135771.16,"total_display":"135,771.16","total_whole":"135,771","shares_owned_after":2563762.0,"shares_owned_after_display":"2,563,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-19","scope":"insider"},{"id":7844232,"accession":"0001104659-23-080572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-080572","line_url":"/filing/0001104659-23-080572#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3285.0,"shares_display":"3,285","price_per_share":15.09,"price_display":"15.09","price_state":"stated","total_value":49570.65,"total_display":"49,570.65","total_whole":"49,571","shares_owned_after":2554613.0,"shares_owned_after_display":"2,554,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":7925086,"accession":"0001104659-23-080178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-080178","line_url":"/filing/0001104659-23-080178#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":153600.0,"total_display":"153,600.00","total_whole":"153,600","shares_owned_after":2551328.0,"shares_owned_after_display":"2,551,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-12","scope":"insider"},{"id":8697525,"accession":"0001104659-23-079339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-079339","line_url":"/filing/0001104659-23-079339#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8948.0,"shares_display":"8,948","price_per_share":15.19,"price_display":"15.19","price_state":"stated","total_value":135920.12,"total_display":"135,920.12","total_whole":"135,920","shares_owned_after":2541328.0,"shares_owned_after_display":"2,541,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-10","scope":"insider"},{"id":8758849,"accession":"0001104659-23-078942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078942","line_url":"/filing/0001104659-23-078942#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3179.0,"shares_display":"3,179","price_per_share":15.01,"price_display":"15.01","price_state":"stated","total_value":47716.79,"total_display":"47,716.79","total_whole":"47,717","shares_owned_after":2532380.0,"shares_owned_after_display":"2,532,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-07","scope":"insider"},{"id":8522051,"accession":"0001104659-23-078475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078475","line_url":"/filing/0001104659-23-078475#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1176.0,"shares_display":"1,176","price_per_share":15.52,"price_display":"15.52","price_state":"stated","total_value":18251.52,"total_display":"18,251.52","total_whole":"18,252","shares_owned_after":2529201.0,"shares_owned_after_display":"2,529,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-06","scope":"insider"},{"id":8001093,"accession":"0001104659-23-075031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-075031","line_url":"/filing/0001104659-23-075031#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16760.0,"shares_display":"16,760","price_per_share":16.46,"price_display":"16.46","price_state":"stated","total_value":275869.6,"total_display":"275,869.60","total_whole":"275,870","shares_owned_after":2528025.0,"shares_owned_after_display":"2,528,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-27","scope":"insider"},{"id":8052575,"accession":"0001104659-23-074561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-074561","line_url":"/filing/0001104659-23-074561#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73175.0,"shares_display":"73,175","price_per_share":17.43,"price_display":"17.43","price_state":"stated","total_value":1275440.25,"total_display":"1,275,440.25","total_whole":"1,275,440","shares_owned_after":2511265.0,"shares_owned_after_display":"2,511,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":8253694,"accession":"0001104659-23-074060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-074060","line_url":"/filing/0001104659-23-074060#line-2","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6999.0,"shares_display":"6,999","price_per_share":17.73,"price_display":"17.73","price_state":"stated","total_value":124092.27,"total_display":"124,092.27","total_whole":"124,092","shares_owned_after":2438090.0,"shares_owned_after_display":"2,438,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-23","scope":"insider"},{"id":8253692,"accession":"0001104659-23-074060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-074060","line_url":"/filing/0001104659-23-074060#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6091.0,"shares_display":"6,091","price_per_share":17.71,"price_display":"17.71","price_state":"stated","total_value":107871.61,"total_display":"107,871.61","total_whole":"107,872","shares_owned_after":2431091.0,"shares_owned_after_display":"2,431,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":8001075,"accession":"0001104659-23-072614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-072614","line_url":"/filing/0001104659-23-072614#line-1","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12700.0,"shares_display":"12,700","price_per_share":17.75,"price_display":"17.75","price_state":"stated","total_value":225425.0,"total_display":"225,425.00","total_whole":"225,425","shares_owned_after":2425000.0,"shares_owned_after_display":"2,425,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider"},{"id":8473129,"accession":"0001104659-23-071869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-071869","line_url":"/filing/0001104659-23-071869","is_derivative":false,"issuer_cik":"0001806384","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001806384","owner_cik":"0001806384","owner_name":"Mosseri Marlio Charles","owner_display_name":"Mosseri Marlio Charles","owner_url":"/insider/0001806384","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32124.0,"shares_display":"32,124","price_per_share":17.707883202589965,"price_display":"17.71","price_state":"stated","total_value":568848.04,"total_display":"568,848.04","total_whole":"568,848","shares_owned_after":2412300.0,"shares_owned_after_display":"2,412,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":46,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001875558","name":"Nuvectis Pharma, Inc.","url":"/issuer/0001875558","role":"Ten percent owner","n_filings":27,"first_seen":"2023-06-16","last_seen":"2026-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001806384","retrieved_at":"2026-08-23T17:09:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}